anti-asthmatic agents

Preferred Label : anti-asthmatic agents;

MeSH definition : Drugs that are used to treat asthma.;

MeSH synonym : drugs, anti-asthmatic; agents, antiasthmatic; antiasthmatic agents; antiasthmatic drugs; anti asthmatics; agents, anti-asthmatic; drugs, antiasthmatic; anti-asthmatic drugs; anti asthmatic drugs; antiasthmatics; anti-asthmatics; anti asthmatic agents; Anti-Asthmatic Drug; Anti Asthmatic Drug; Drug, Anti-Asthmatic; Anti-Asthmatic; Anti Asthmatic; Antiasthmatic Agent; Agent, Antiasthmatic; Antiasthmatic Drug; Drug, Antiasthmatic; Anti-Asthmatic Agent; Agent, Anti-Asthmatic; Anti Asthmatic Agent; Antiasthmatic;

MeSH annotation : consider also ASTHMA /drug ther;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D018927;

UMLS CUI

C0282556;

ATC code(s)
- flunisolide [ATC Code]
- glycopyrronium bromide [ATC Code]
- tiotropium bromide [ATC Code]
ATC code(s)
- adrenergics, inhalants [ATC Code]
- anticholinergics [ATC Code]
- combinations of adrenergics [ATC Code]
- combinations of xanthines [ATC Code]
- epinephrine and other drugs for obstructive airway diseases [ATC Code]
- glucocorticoids [ATC Code]
- isoprenaline and other drugs for obstructive airway diseases [ATC Code]
- other drugs for obstructive airway diseases, inhalants [ATC Code]
- salbutamol [ATC Code]
- selective beta-2-adrenoreceptor agonists [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Antiasthmatic drug [ICHI extension code]
- Drug-induced asthma [MedDRA LLT]
- Respiratory smooth muscle relaxant (product) [Inactive SNOMED CT concept]
- respiratory smooth muscle relaxant, nos [SNOMED Notion]
CISMeF manual mappings
- Antiasthmatics, not elsewhere classified [Bloc CIM-11]
Currated CISMeF NLP mapping
- Anti-asthmatic Agent [NCIt concept]
- Antiasthmatic drug [ICD-11 Extension code]
Indexing information
- 2,2,2-trifluoro-N-(1-((1-(4-fluorophenyl)-1H-indazol-5-yl)oxy)-1-(3-methoxyphenyl)-2-propanyl)acetamide [MeSH Supplementary Concept]
- ASP5642 [MeSH Supplementary Concept]
- EPs 7630 [MeSH Supplementary Concept]
- N-(3-(5-(1H-tetrazol))pheny)-2-(4-isobutylphenyl)propionamide [MeSH Supplementary Concept]
- dupilumab [MeSH Supplementary Concept]
- ethyl 3',4',5'-trimethoxythionocinnamate [MeSH Supplementary Concept]
- fenspiride [MeSH Supplementary Concept]
- fluticasone-formoterol [MeSH Supplementary Concept]
Record concept(s)
- Anti-Asthmatic agents [MeSH concept]
See also
- asthma [MeSH Descriptor]
See also inter- (CISMeF)
- Medicinal product acting as antiasthmatic agent (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- Budesonide, Formoterol Fumarate Drug Combination [MeSH Descriptor]
- Omalizumab [MeSH Descriptor]
- U 78517F [MeSH Supplementary Concept]
- acetosyringone [MeSH Supplementary Concept]
- baicalin [MeSH Supplementary Concept]
- beclomethasone [MeSH Descriptor]
- benralizumab [MeSH Supplementary Concept]
- betamethasone [MeSH Descriptor]
- carebastine [MeSH Supplementary Concept]
- cromolyn sodium [MeSH Descriptor]
- ephedrine, proxyphylline drug combination [MeSH Supplementary Concept]
- flunisolide [MeSH Supplementary Concept]
- leukotriene antagonists [MeSH Descriptor]
- montelukast [MeSH Supplementary Concept]
- nedocromil [MeSH Descriptor]
- oxatomide [MeSH Supplementary Concept]
- pranlukast [MeSH Supplementary Concept]
- reslizumab [MeSH Supplementary Concept]
- seratrodast [MeSH Supplementary Concept]
- zafirlukast [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Anti-asthmatic Agent [NCIt concept]
- Antiasthmatic drug [ICD-11 Extension code]
- Antiasthmatics, not elsewhere classified [Bloc CIM-11]
- Medicinal product acting as antiasthmatic agent (product) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients